Using angiogenic factors to manage gestational hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the role of angiogenic factors in the conservative management of gestational hypertension, a condition that poses risks to both mothers and their babies. By analyzing these factors, the study aims to differentiate between patients who may face complications and those who could benefit from prolonging their pregnancy. The approach focuses on pregnant women diagnosed with gestational hypertension, utilizing specific biomarkers to guide clinical decisions regarding the timing of delivery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pregnant women between 24 and 40 weeks of gestation.
* Diagnosis of Gestational Hypertension based on ACOG criteria
* index sFlt-1/PIGF equal or below 33

Exclusion Criteria:

* Multiple gestation
* Maternal vasculitis
* Previous cesarean section (3 or more)
* Neurological conditions
* Chronic renal disease
* Purpura
* Heart disease
* Index sFlt-1/PIGF of 34 or more

Where it's running

• Hospital Santo Tomas
  Panama City, Provincia de Panamá, Panama Recruiting

Study contacts

• Study coordinator: Osvaldo Reyes, MD
• Email: oreyespanama@yahoo.es
• Phone: +507 65655041

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MH-Rx: Check-in on You, Your Medication, and Your Blood Pressure for Pregnant People

  This trial tests whether adding virtual social-support and medication management to remote blood pressure monitoring helps pregnant people with chronic or gestational hypertension.

  Recruiting Texas Southern University · Houston, Texas · NCT07842341

• Community health worker support to lower blood pressure after pregnancy with high blood pressure

  Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07778966

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

• Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy

  This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.

  Recruiting Phase 4 Alexandra Hospital, Athens, Greece · Athens, Attica · NCT07361679

• Blood markers (sFlt-1/PlGF, sEng, OPG) for diagnosing and monitoring preeclampsia

  This study will test whether three blood markers—the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)—can help diagnose and track preeclampsia in pregnant women between 20 and 36 weeks of gestation.

  Recruiting University of Thi-Qar · Nasiriyah, Dhi Qar · NCT07349277

• Postpartum high blood pressure: trying enalapril after delivery

  This study tests whether giving enalapril after delivery can help postpartum women with hypertensive disorders of pregnancy manage blood pressure.

  Recruiting Phase 3 Women and Infants Hospital of Rhode Island · Providence, Rhode Island · NCT07222852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.